Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 33,500 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 33,500 | n/a |
| Jun 30, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Exercise/Conversion | 203 | n/a |
| Apr 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,269 | $5.8K |
| Oct 3, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 100,000 | n/a |
| Aug 13, 2025 | Longeveron Inc. (LGVN) | Purchase | 11,766 | n/a |
| Jul 28, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 175,299 | n/a |
| Jul 17, 2025 | Longeveron Inc. (LGVN) | Grant/Award | 17,000 | n/a |
| Dec 4, 2024 | Longeveron Inc. (LGVN) | Sale | 1,250 | $2.6K |
| Sep 18, 2024 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 31,206 | n/a |
| Aug 20, 2024 | Longeveron Inc. (LGVN) | Grant/Award | 23,500 | n/a |